Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Skycrest Holdings, LLC Insider Profile
4 Followers
Skycrest Holdings, LLC, Ten Percent Owner at Organicell Regenerative Medicine, holds 51.72M shares in Organicell Regenerative Medicine (Ticker: OCEL).
Skycrest Holdings, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Skycrest Holdings, LLC's holdings
Insider Roles
Ten Percent Owner
Roles that Skycrest Holdings, LLC holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Skycrest Holdings, LLC
Skycrest Holdings, LLC's Trading History
List of latest transactions for each holding click on a transaction to see Skycrest Holdings, LLC's performance on stock
You May Also Like
Skycrest Holdings, LLC insider profile FAQ
What is the percentage of profitable transactions made by Skycrest Holdings, LLC?
The percentage of profitable transactions made by Skycrest Holdings, LLC is ―.
What is the average return per transaction made by Skycrest Holdings, LLC?
The average return per transaction made by Skycrest Holdings, LLC is ―.
What stocks does Skycrest Holdings, LLC hold?
Skycrest Holdings, LLC holds: OCEL stocks.
What was Skycrest Holdings, LLC’s latest transaction?
Skycrest Holdings, LLC latest transaction was an Uninformative Buy of ―.
What was Skycrest Holdings, LLC's most profitable transaction?
Skycrest Holdings, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Skycrest Holdings, LLC's role in Organicell Regenerative Medicine?
Skycrest Holdings, LLC's role in Organicell Regenerative Medicine is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.